PUBLISHER: IMARC | PRODUCT CODE: 1347608
PUBLISHER: IMARC | PRODUCT CODE: 1347608
The global medical foam market size reached US$ 29.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 42.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028.
Medical foam refers to an antimicrobial product used in numerous medical devices, components, and support materials, such as surgical drapes, wound dressing, and bedding materials in the healthcare industry. It is manufactured using cell polyurethane, polymers and metals. Medical foam is also widely used in prosthetic padding, custom orthotics, sealing ostomy equipment and body underfoot pressure relief equipment. It exhibits various properties, such as water, strain and fungal resistance, softness, durability, sterility, and versatility, thus making it suitable for protective packaging purposes. Medical foams offer compression relieving capabilities that adapt to the patient's body shape and assist in providing comfort, relaxation and alleviating pressure relief points. Currently, it is available in rigid, flexible, and molded product types.
The rising geriatric population across the globe that are more prone to developing various chronic ailments represents one of the key factors driving the growth of the market. Medical foam plays a vital role during patient recovery post major surgeries as they are widely used in bedding and cushioning products to enhance comfort. Additionally, the increasing usage of medical foam in numerous applications, such as medical system cushioning and wound dressings, due to its various properties, such as excellent compression-set resistance, impact-absorbing and versatility, is favoring the market growth. Apart from this, increasing cases of epidemic outbreaks, such as coronavirus disease (COVID-19) and swine flu, along with rising health concerns among people related to personal hygiene, are providing an impetus to the market growth. Moreover, the increasing demand for heat and moisture exchange (HME) foams in medical breathing and anesthesia systems and equipment that provide a consistent and controlled oxygen and gas intake, while also ensuring sterile conditions are positively impacting the market growth. Other factors, including the significant expansion in the medical industry, increasing demand for implantable medical devices, and the shifting inclination from traditional to advanced wound care products are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical foam market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, material and application.
Rigid
Flexible
Molded
Polymers
Metals
Other
Bedding and Cushioning
Medical Packaging
Medical Devices and Components
Prosthetics and Wound Care
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Medical Solutions Group Plc, BASF SE, Draka Interfoam B.V., Foamtec Medical, Freudenberg Performance Materials, FXI, General Plastics Manufacturing Company Inc., Global Medical Foam Inc., Inoac Corporation, Recticel NV, Rogers Corporation, SEKISUI CHEMICAL CO. LTD. and Ufp Technologies Inc.